ENTPD1 and neoplasm: Different reports have described the expression of CD39 and CD73 ectonucleotidases in an inflammatory context (Antonioli et al., 2013; Allard et al., 2017), but most of these reports focus on the presence of these molecules in tumor cells or regulatory cells, overlooking other populations such as CD8+ T cells.